Acta Pharmacologica Sinica, Published online: 01 June 2026; doi:10.1038/s41401-026-01828-3 Discovery of a novel dual-target modulator of ULK1 and ERK1/2 that suppresses triple-negative breast cancer progression and metastasis via the Exo70/Cav-1/MMPs axis